Methylene Blue Injection, Solution
NDC Package 70121-2716-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Methylene Blue injection is uSP is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia. This formulation utilizes a injection, solution delivery system. Marketed by Amneal Pharmaceuticals Llc, this product is identified by NDC 70121-2716 and is authorized under FDA application ANDA216955.

Identification & Billing

NDC Package Code
70121-2716-2
Package Description
5 SYRINGE in 1 BOX / 10 mL in 1 SYRINGE
Product Code
70121-2716
11-Digit Billing Format
70121271602
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Methylene Blue
Non-Proprietary Name
Methylene Blue
Substance Name
Methylene Blue
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
METHYLENE BLUE 5 mg/mL
Pharmacologic Class
Usage Information
Methylene blue injection, USP is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.

Regulatory & Marketing

Labeler Name
Amneal Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA216955
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-03-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70121-2716-2 identifies a specific commercial package of 5 syringe in 1 box / 10 ml in 1 syringe of Methylene Blue, a human prescription drug labeled by Amneal Pharmaceuticals Llc. This injection, solution is formulated for intravenous use and contains methylene blue as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Llc on March 03, 2025. The current certification is valid through December 31, 2027.

How is this Amneal Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70121271602. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70121-2716-2
11-Digit CMS (5-4-2)
70121-2716-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.